Domestic stocks logged modest losses weighed by negative global cues after the US Federal Reserve raised interest rates and struck a hawkish tone in its latest policy statement. The barometer index, the S&P BSE Sensex, lost 139.34 points or 0.39% at 35,599.82, as per the provisional closing data. The Nifty 50 index fell 47.45 points or 0.44% at 10,809.25, as per the provisional closing data.
Domestic stocks edged lower in early trade tracking negative Asian stocks after the US Federal Reserve struck a hawkish tone in its latest policy statement. Fresh selling in index pivotals pulled the key benchmark indices to intraday low in morning trade. Stocks continued to trade with weakness in mid-morning trade. Key equity benchmarks trimmed losses after hitting fresh intraday low in afternoon trade. Indices staged a pullback in mid-afternoon trade. Stocks hovered with negative bias in late trade.
The S&P BSE Mid-Cap index fell 0.08%. The S&P BSE Small-Cap index rose 0.07%. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was negative. On the BSE, 1234 shares rose and 1390 shares fell. A total of 135 shares were unchanged.
HDFC Bank fell 0.16%. The Union Cabinet chaired by the Prime Minister Narendra Modi has approved the proposal for grant of permission to HDFC Bank to raise additional share capital of up to a maximum of Rs 24000 crore, including premium, over and above the previous approved limit of Rs 10000 crore, such that the composite foreign shareholding in the bank shall not exceed 74% of the enhanced paid-up equity share capital of the bank, the Ministry of Finance said in a statement yesterday, 13 June 2018.
The decision would ensure that the composite foreign shareholding in the bank inclusive of all types of foreign investments, both direct and indirect, will not exceed 74% of the enhanced paid-up equity share capital of the bank. It will be subject to Foreign Direct Investment Policy conditionalities and other sectoral regulations / guidelines. The proposed investment is expected to strengthen the capital adequacy ratio of the bank, the statement added.
Engineering and construction major L&T shed 0.78%. L&T Hydrocarbon Engineering (LTHE), a wholly owned subsidiary of L&T, has won new orders in excess of Rs 750 crore in its Construction Services business vertical. The Water & Effluent Treatment business secured orders worth Rs 432 crore. The Smart World & Communication business has secured an order worth Rs 209 crore. The announcement was made during market hours today, 14 June 2018.
HCL Technologies rose 1.24%. HCL Technologies announced it has signed an end-to-end IT infrastructure services deal with Falck, an international leader in the ambulance and healthcare markets. The announcement was made during trading hours today, 14 June 2018.
Through this deal, HCL will support Falck's business transformation by consolidating, simplyfing and standardizing Falck's IT infrastructure operations through a centralised global service delivery model. The new centralised model will enable greater automation, improved cost transparency, enhanced operational efficiency and increased control. The delivery hubs for this engagement will include HCL's newly inaugurated Global Delivery Centre in Gothenburg, Sweden and sites in the US and South America.
Cipla rose 1.47%. Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (USFDA). Cipla's Isoproterenol Hydrochloride injection USP, indicated for the treatment of cardiac problems, ampoule is AP-rated generic therapeutic equivalent version of Hospira Inc's Isuprel injection. According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately $148 million for the 12-month period ending April 2018. The announcement was made after market hours yesterday, 13 June 2018.
Separately, Cipla said its Ugandan subsidiary, Cipla Quality Chemical Industries (CiplaQCIL), intends on partnering with the government of Uganda to increase access to cancer treatments. And as part of its growth strategy, CiplaQCIL is evaluating an initial public offering. In the event that this is achieved, a section of the public will have a stake in the company. The transaction would be subject to approval from the relevant market regulators. The announcement was made after market hours yesterday, 13 June 2018.
Lupin advanced 3.73% announced the launch of its Tobramycin Inhalation Solution USP, having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tobramycin Inhalation Solution USP, 300 mg/5 ml is the generic equivalent of Novartis Pharmaceuticals Corporation's Tobi 300 mg/5 ml. It is indicated for the management of cystic fibrosis patients with P. aeruginosa. Tobramycin Inhalation Solution USP, 300 mg/5 ml had annual sales of approximately $99 million in the US (IQVIA MAT April 2018). The announcement was made after market hours yesterday, 13 June 2018.
Hindusthan National Glass & Industries hit an upper circuit limit of 20% at Rs 92.70. Hindusthan National Glass & Industries said it has entered into a share purchase agreement for divesting its entire 11.23% holding in HNG Float Glass, a joint venture of the company, to Trakya Cam Sanayii AS. The announcement was made after market hours yesterday, 13 June 2018.
Hindusthan National Glass said it has transferred 3.45 crore equity shares to Trakya Cam Sanayii AS for $19.26 million (Rs 129.76 crore). HNG Float Glass has posted a turnover of Rs 554.18 crore during 2017-2018 with a net worth of Rs 421.54 crore as on 31 March 2018. Trakya Cam Sanayii AS is a large float glass manufacturing group in Europe with its presence all over Europe.
On the macro front, the annual rate of inflation, based on monthly Wholesale Price Index (WPI), stood at 4.43% (provisional) for May 2018 (over May 2017) as compared to 3.18% (provisional) for the previous month and 2.26% during the corresponding month of the previous year. The data was unveiled during trading hours today, 14 June 2018.
India's current account deficit (CAD) widened in the fourth quarter of 2017-18 compared to a year ago, government data released after market hours yesterday, 13 June 2018 showed. India's CAD at US$ 13 billion (1.9% of GDP) in Q4 of 2017-18 increased from US$ 2.6 billion (0.4% of GDP) in Q4 of 2016 -17, but moderated marginally from US$ 13.7 billion (2.1% of GDP) in the preceding quarter. The widening of the CAD on a year-on-year (y-o-y) basis was primarily on account of a higher trade deficit (US$ 41.6 billion) brought about by a larger increase in merchandise imports relative to exports.
For the full year, the CAD increased to 1.9% of GDP in 2017-18 from 0.6% in 2016-17 on the back of a widening of the trade deficit. India's trade deficit increased to US$ 160 billion in 2017-18 from US$ 112.4 billion in 2016-17.
Traders and investors are closely awaiting a series of domestic and global events this week. On the global front, the European Central Bank (ECB) will hold its policy meeting today, 14 June 2018, in which policy makers are poised to hold formal talks on ending its bond-buying program. The Bank of Japan meets tomorrow, 15 June 2018 with no change to policy expected.
Overseas, European stocks dropped as mining shares were bruised by concerns about China's economic health after downbeat data. China is the world's largest buyer of copper and a major buyer of other industrial and precious metals.
Asian stocks followed US equities lower as the Federal Reserve struck a hawkish tone in its latest policy statement. US stock benchmarks ended near session lows yesterday, 13 June 2018, as the Federal Reserve completed its second increase to benchmark interest rates in 2018, as expected, but signaled a slightly more aggressive plan to tighten monetary policy this year than had previously been projected.
The Federal Reserve voted to raise its benchmark federal-funds rate by a quarter percentage point to a range of 1.75% to 2%. Policymakers also projected a slightly faster pace of rate increases in the coming months, with two additional hikes expected by the end of this year, compared to one previously. They see another three rate increases next year, a pace unchanged from their previous forecast.
Chairman Jerome Powell said the Fed was comfortable with a return of once-dormant inflation and emphasized the central bank's desire to avoid a policy error that could result in unnaturally inflating asset valuations or pushing the economy into a recession.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
